Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Holders of 5% or more of ACGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aceragen, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Aceragen, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Aceragen, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2023 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Jul 17, 2023 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 10, 2023 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 28, 2023 | Chopra Atul | 13DOld format | – | New | – | SEC |
| Feb 14, 2023 | Castellina Ventures Ltd. | 13G/AOld format | – | – | – | SEC |
| Jan 30, 2023 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 18, 2023 | NovaQuest Co-Investment Fund XV, L.P. | 13DOld format | – | New | – | SEC |
| Oct 5, 2022 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Jul 1, 2022 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 24, 2022 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 7, 2022 | Castellina Ventures Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | Castellina Ventures Ltd. | 13G/AOld format | – | – | – | SEC |
| Jun 7, 2021 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 9, 2021 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Apr 1, 2021 | Pillar Pharmaceuticals 6, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Castellina Ventures Ltd. | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2021 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
8 notices from officers, directors and other affiliates planning to sell Aceragen, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 20234:25 PM ET | BM For MG Gift TrustDirector | 51 | $26.01 | Aug 10, 2023 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 10, 20231:49 PM ET | Milano VincentDirector | 3.28K | $1.90K | Aug 10, 2023 | Charles Schwab Corporation | SEC |
| Jul 25, 20233:55 PM ET | John KirbyOfficer | 18.7K | $12.3K | Jul 25, 2023 | UBS Financial Services Inc | SEC |
| May 17, 20232:59 PM ET | Chopra Atul10% stockholder | 24.8K | $32.4K | May 17, 2023 | Wells Fargo Advisors | SEC |
| May 17, 20239:49 AM ET | Chopra Atul10% stockholder | 32.4K | $45.0K | May 16, 2023 | Wells Fargo Advisors | SEC |
| May 15, 20234:16 PM ET | Chopra Atul10% stockholder | 74.9K | $109.5K | May 15, 2023 | Wells Fargo Advisors | SEC |
| May 12, 20234:24 PM ET | Chopra Atul10% stockholder | 81.5K | $125.2K | May 12, 2023 | Wells Fargo Advisors | SEC |
| May 11, 20234:23 PM ET | Chopra Atul10% stockholder | 47.2K | $86.4K | May 11, 2023 | Wells Fargo Advisors | SEC |